EGFR and non-small cell lung carcinoma: The THC:CBD combination (10 μM each) was the most effective at inhibiting NSCLC cell proliferation and in downregulating the gene expression of epidermal growth factor receptor (EGFR), which was not observed in the treatments with cannabinoids alone [31].